 | • レポートコード：MRC2-11QY11482 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は便秘のグローバル市場について調査・分析したレポートです。種類別（慢性特発性便秘（CIC）、過敏性腸症候群（IBS-C）、オピオイド誘発性便秘（OIC））市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別便秘の競争状況、市場シェア ・世界の便秘市場：種類別市場規模 2015年-2020年（慢性特発性便秘（CIC）、過敏性腸症候群（IBS-C）、オピオイド誘発性便秘（OIC）） ・世界の便秘市場：種類別市場規模予測 2021年-2026年（慢性特発性便秘（CIC）、過敏性腸症候群（IBS-C）、オピオイド誘発性便秘（OIC）） ・世界の便秘市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の便秘市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の便秘市場分析：米国、カナダ ・ヨーロッパの便秘市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの便秘市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の便秘市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの便秘市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Takeda Pharmaceutical、Synergy Pharmaceuticals、Sucampo Pharmaceuticals、Ironwood Pharmaceuticals、Bausch Health、Abbott、AstraZeneca、Cosmo Pharmaceuticals、Sanofi、Daewoong Pharmaceuticals、Bayer、Prestige Brands Holdings、Janssen Pharmaceutical、Shionogi、Albireo Pharma、Renexxion ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Constipation is common disease which is estimated to affect each individual once in life time. According to international as well regional guidelines it is characterized by frequency and nature of bowel movement. Less than 2 bowel movements per week, associated with hard stool and strain in passing is termed as constipation. Constipation may be occasional which lasts for few weeks or may be chronic which lasts for longer period and is recurrent. It may be associated with other conditions such as irritable bowel syndrome or opioid consumption.
Based on disease type, the global constipation treatment market is segmented into chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C) and opioid induced constipation (OIC). High prevalence of chronic constipation is estimated to contribute for dominating share of CIC segment in global market while increasing opioid consumption is projected to propel for exponential growth of OIC segment during forecast period.
Market Analysis and Insights: Global Constipation Market
The global Constipation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Constipation Scope and Market Size
Constipation market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Constipation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Takeda Pharmaceutical
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Bausch Health
Abbott
AstraZeneca
Cosmo Pharmaceuticals
Sanofi
Daewoong Pharmaceuticals
Bayer
Prestige Brands Holdings
Janssen Pharmaceutical
Shionogi
Albireo Pharma
Renexxion
Market segment by Type, the product can be split into
Chronic Idiopathic Constipation (CIC)
Irritable Bowel Syndrome With Constipation (IBS-C)
Opioid-Induced Constipation (OIC)
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Constipation Revenue
1.4 Market by Type
1.4.1 Global Constipation Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chronic Idiopathic Constipation (CIC)
1.4.3 Irritable Bowel Syndrome With Constipation (IBS-C)
1.4.4 Opioid-Induced Constipation (OIC)
1.5 Market by Application
1.5.1 Global Constipation Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Constipation Market Perspective (2015-2026)
2.2 Global Constipation Growth Trends by Regions
2.2.1 Constipation Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Constipation Historic Market Share by Regions (2015-2020)
2.2.3 Constipation Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Constipation Market Growth Strategy
2.3.6 Primary Interviews with Key Constipation Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Constipation Players by Market Size
3.1.1 Global Top Constipation Players by Revenue (2015-2020)
3.1.2 Global Constipation Revenue Market Share by Players (2015-2020)
3.1.3 Global Constipation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Constipation Market Concentration Ratio
3.2.1 Global Constipation Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Constipation Revenue in 2019
3.3 Constipation Key Players Head office and Area Served
3.4 Key Players Constipation Product Solution and Service
3.5 Date of Enter into Constipation Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Constipation Historic Market Size by Type (2015-2020)
4.2 Global Constipation Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Constipation Market Size by Application (2015-2020)
5.2 Global Constipation Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Constipation Market Size (2015-2020)
6.2 Constipation Key Players in North America (2019-2020)
6.3 North America Constipation Market Size by Type (2015-2020)
6.4 North America Constipation Market Size by Application (2015-2020)
7 Europe
7.1 Europe Constipation Market Size (2015-2020)
7.2 Constipation Key Players in Europe (2019-2020)
7.3 Europe Constipation Market Size by Type (2015-2020)
7.4 Europe Constipation Market Size by Application (2015-2020)
8 China
8.1 China Constipation Market Size (2015-2020)
8.2 Constipation Key Players in China (2019-2020)
8.3 China Constipation Market Size by Type (2015-2020)
8.4 China Constipation Market Size by Application (2015-2020)
9 Japan
9.1 Japan Constipation Market Size (2015-2020)
9.2 Constipation Key Players in Japan (2019-2020)
9.3 Japan Constipation Market Size by Type (2015-2020)
9.4 Japan Constipation Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Constipation Market Size (2015-2020)
10.2 Constipation Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Constipation Market Size by Type (2015-2020)
10.4 Southeast Asia Constipation Market Size by Application (2015-2020)
11 India
11.1 India Constipation Market Size (2015-2020)
11.2 Constipation Key Players in India (2019-2020)
11.3 India Constipation Market Size by Type (2015-2020)
11.4 India Constipation Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Constipation Market Size (2015-2020)
12.2 Constipation Key Players in Central & South America (2019-2020)
12.3 Central & South America Constipation Market Size by Type (2015-2020)
12.4 Central & South America Constipation Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Takeda Pharmaceutical
13.1.1 Takeda Pharmaceutical Company Details
13.1.2 Takeda Pharmaceutical Business Overview
13.1.3 Takeda Pharmaceutical Constipation Introduction
13.1.4 Takeda Pharmaceutical Revenue in Constipation Business (2015-2020))
13.1.5 Takeda Pharmaceutical Recent Development
13.2 Synergy Pharmaceuticals
13.2.1 Synergy Pharmaceuticals Company Details
13.2.2 Synergy Pharmaceuticals Business Overview
13.2.3 Synergy Pharmaceuticals Constipation Introduction
13.2.4 Synergy Pharmaceuticals Revenue in Constipation Business (2015-2020)
13.2.5 Synergy Pharmaceuticals Recent Development
13.3 Sucampo Pharmaceuticals
13.3.1 Sucampo Pharmaceuticals Company Details
13.3.2 Sucampo Pharmaceuticals Business Overview
13.3.3 Sucampo Pharmaceuticals Constipation Introduction
13.3.4 Sucampo Pharmaceuticals Revenue in Constipation Business (2015-2020)
13.3.5 Sucampo Pharmaceuticals Recent Development
13.4 Ironwood Pharmaceuticals
13.4.1 Ironwood Pharmaceuticals Company Details
13.4.2 Ironwood Pharmaceuticals Business Overview
13.4.3 Ironwood Pharmaceuticals Constipation Introduction
13.4.4 Ironwood Pharmaceuticals Revenue in Constipation Business (2015-2020)
13.4.5 Ironwood Pharmaceuticals Recent Development
13.5 Bausch Health
13.5.1 Bausch Health Company Details
13.5.2 Bausch Health Business Overview
13.5.3 Bausch Health Constipation Introduction
13.5.4 Bausch Health Revenue in Constipation Business (2015-2020)
13.5.5 Bausch Health Recent Development
13.6 Abbott
13.6.1 Abbott Company Details
13.6.2 Abbott Business Overview
13.6.3 Abbott Constipation Introduction
13.6.4 Abbott Revenue in Constipation Business (2015-2020)
13.6.5 Abbott Recent Development
13.7 AstraZeneca
13.7.1 AstraZeneca Company Details
13.7.2 AstraZeneca Business Overview
13.7.3 AstraZeneca Constipation Introduction
13.7.4 AstraZeneca Revenue in Constipation Business (2015-2020)
13.7.5 AstraZeneca Recent Development
13.8 Cosmo Pharmaceuticals
13.8.1 Cosmo Pharmaceuticals Company Details
13.8.2 Cosmo Pharmaceuticals Business Overview
13.8.3 Cosmo Pharmaceuticals Constipation Introduction
13.8.4 Cosmo Pharmaceuticals Revenue in Constipation Business (2015-2020)
13.8.5 Cosmo Pharmaceuticals Recent Development
13.9 Sanofi
13.9.1 Sanofi Company Details
13.9.2 Sanofi Business Overview
13.9.3 Sanofi Constipation Introduction
13.9.4 Sanofi Revenue in Constipation Business (2015-2020)
13.9.5 Sanofi Recent Development
13.10 Daewoong Pharmaceuticals
13.10.1 Daewoong Pharmaceuticals Company Details
13.10.2 Daewoong Pharmaceuticals Business Overview
13.10.3 Daewoong Pharmaceuticals Constipation Introduction
13.10.4 Daewoong Pharmaceuticals Revenue in Constipation Business (2015-2020)
13.10.5 Daewoong Pharmaceuticals Recent Development
13.11 Bayer
10.11.1 Bayer Company Details
10.11.2 Bayer Business Overview
10.11.3 Bayer Constipation Introduction
10.11.4 Bayer Revenue in Constipation Business (2015-2020)
10.11.5 Bayer Recent Development
13.12 Prestige Brands Holdings
10.12.1 Prestige Brands Holdings Company Details
10.12.2 Prestige Brands Holdings Business Overview
10.12.3 Prestige Brands Holdings Constipation Introduction
10.12.4 Prestige Brands Holdings Revenue in Constipation Business (2015-2020)
10.12.5 Prestige Brands Holdings Recent Development
13.13 Janssen Pharmaceutical
10.13.1 Janssen Pharmaceutical Company Details
10.13.2 Janssen Pharmaceutical Business Overview
10.13.3 Janssen Pharmaceutical Constipation Introduction
10.13.4 Janssen Pharmaceutical Revenue in Constipation Business (2015-2020)
10.13.5 Janssen Pharmaceutical Recent Development
13.14 Shionogi
10.14.1 Shionogi Company Details
10.14.2 Shionogi Business Overview
10.14.3 Shionogi Constipation Introduction
10.14.4 Shionogi Revenue in Constipation Business (2015-2020)
10.14.5 Shionogi Recent Development
13.15 Albireo Pharma
10.15.1 Albireo Pharma Company Details
10.15.2 Albireo Pharma Business Overview
10.15.3 Albireo Pharma Constipation Introduction
10.15.4 Albireo Pharma Revenue in Constipation Business (2015-2020)
10.15.5 Albireo Pharma Recent Development
13.16 Renexxion
10.16.1 Renexxion Company Details
10.16.2 Renexxion Business Overview
10.16.3 Renexxion Constipation Introduction
10.16.4 Renexxion Revenue in Constipation Business (2015-2020)
10.16.5 Renexxion Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Constipation Key Market Segments
Table 2. Key Players Covered: Ranking by Constipation Revenue
Table 3. Ranking of Global Top Constipation Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Constipation Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chronic Idiopathic Constipation (CIC)
Table 6. Key Players of Irritable Bowel Syndrome With Constipation (IBS-C)
Table 7. Key Players of Opioid-Induced Constipation (OIC)
Table 8. Global Constipation Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Constipation Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Constipation Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Constipation Market Share by Regions (2015-2020)
Table 12. Global Constipation Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Constipation Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Constipation Market Growth Strategy
Table 18. Main Points Interviewed from Key Constipation Players
Table 19. Global Constipation Revenue by Players (2015-2020) (Million US$)
Table 20. Global Constipation Market Share by Players (2015-2020)
Table 21. Global Top Constipation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Constipation as of 2019)
Table 22. Global Constipation by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Constipation Product Solution and Service
Table 25. Date of Enter into Constipation Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Constipation Market Size by Type (2015-2020) (Million US$)
Table 28. Global Constipation Market Size Share by Type (2015-2020)
Table 29. Global Constipation Revenue Market Share by Type (2021-2026)
Table 30. Global Constipation Market Size Share by Application (2015-2020)
Table 31. Global Constipation Market Size by Application (2015-2020) (Million US$)
Table 32. Global Constipation Market Size Share by Application (2021-2026)
Table 33. North America Key Players Constipation Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Constipation Market Share (2019-2020)
Table 35. North America Constipation Market Size by Type (2015-2020) (Million US$)
Table 36. North America Constipation Market Share by Type (2015-2020)
Table 37. North America Constipation Market Size by Application (2015-2020) (Million US$)
Table 38. North America Constipation Market Share by Application (2015-2020)
Table 39. Europe Key Players Constipation Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Constipation Market Share (2019-2020)
Table 41. Europe Constipation Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Constipation Market Share by Type (2015-2020)
Table 43. Europe Constipation Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Constipation Market Share by Application (2015-2020)
Table 45. China Key Players Constipation Revenue (2019-2020) (Million US$)
Table 46. China Key Players Constipation Market Share (2019-2020)
Table 47. China Constipation Market Size by Type (2015-2020) (Million US$)
Table 48. China Constipation Market Share by Type (2015-2020)
Table 49. China Constipation Market Size by Application (2015-2020) (Million US$)
Table 50. China Constipation Market Share by Application (2015-2020)
Table 51. Japan Key Players Constipation Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Constipation Market Share (2019-2020)
Table 53. Japan Constipation Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Constipation Market Share by Type (2015-2020)
Table 55. Japan Constipation Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Constipation Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Constipation Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Constipation Market Share (2019-2020)
Table 59. Southeast Asia Constipation Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Constipation Market Share by Type (2015-2020)
Table 61. Southeast Asia Constipation Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Constipation Market Share by Application (2015-2020)
Table 63. India Key Players Constipation Revenue (2019-2020) (Million US$)
Table 64. India Key Players Constipation Market Share (2019-2020)
Table 65. India Constipation Market Size by Type (2015-2020) (Million US$)
Table 66. India Constipation Market Share by Type (2015-2020)
Table 67. India Constipation Market Size by Application (2015-2020) (Million US$)
Table 68. India Constipation Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Constipation Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Constipation Market Share (2019-2020)
Table 71. Central & South America Constipation Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Constipation Market Share by Type (2015-2020)
Table 73. Central & South America Constipation Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Constipation Market Share by Application (2015-2020)
Table 75. Takeda Pharmaceutical Company Details
Table 76. Takeda Pharmaceutical Business Overview
Table 77. Takeda Pharmaceutical Product
Table 78. Takeda Pharmaceutical Revenue in Constipation Business (2015-2020) (Million US$)
Table 79. Takeda Pharmaceutical Recent Development
Table 80. Synergy Pharmaceuticals Company Details
Table 81. Synergy Pharmaceuticals Business Overview
Table 82. Synergy Pharmaceuticals Product
Table 83. Synergy Pharmaceuticals Revenue in Constipation Business (2015-2020) (Million US$)
Table 84. Synergy Pharmaceuticals Recent Development
Table 85. Sucampo Pharmaceuticals Company Details
Table 86. Sucampo Pharmaceuticals Business Overview
Table 87. Sucampo Pharmaceuticals Product
Table 88. Sucampo Pharmaceuticals Revenue in Constipation Business (2015-2020) (Million US$)
Table 89. Sucampo Pharmaceuticals Recent Development
Table 90. Ironwood Pharmaceuticals Company Details
Table 91. Ironwood Pharmaceuticals Business Overview
Table 92. Ironwood Pharmaceuticals Product
Table 93. Ironwood Pharmaceuticals Revenue in Constipation Business (2015-2020) (Million US$)
Table 94. Ironwood Pharmaceuticals Recent Development
Table 95. Bausch Health Company Details
Table 96. Bausch Health Business Overview
Table 97. Bausch Health Product
Table 98. Bausch Health Revenue in Constipation Business (2015-2020) (Million US$)
Table 99. Bausch Health Recent Development
Table 100. Abbott Company Details
Table 101. Abbott Business Overview
Table 102. Abbott Product
Table 103. Abbott Revenue in Constipation Business (2015-2020) (Million US$)
Table 104. Abbott Recent Development
Table 105. AstraZeneca Company Details
Table 106. AstraZeneca Business Overview
Table 107. AstraZeneca Product
Table 108. AstraZeneca Revenue in Constipation Business (2015-2020) (Million US$)
Table 109. AstraZeneca Recent Development
Table 110. Cosmo Pharmaceuticals Business Overview
Table 111. Cosmo Pharmaceuticals Product
Table 112. Cosmo Pharmaceuticals Company Details
Table 113. Cosmo Pharmaceuticals Revenue in Constipation Business (2015-2020) (Million US$)
Table 114. Cosmo Pharmaceuticals Recent Development
Table 115. Sanofi Company Details
Table 116. Sanofi Business Overview
Table 117. Sanofi Product
Table 118. Sanofi Revenue in Constipation Business (2015-2020) (Million US$)
Table 119. Sanofi Recent Development
Table 120. Daewoong Pharmaceuticals Company Details
Table 121. Daewoong Pharmaceuticals Business Overview
Table 122. Daewoong Pharmaceuticals Product
Table 123. Daewoong Pharmaceuticals Revenue in Constipation Business (2015-2020) (Million US$)
Table 124. Daewoong Pharmaceuticals Recent Development
Table 125. Bayer Company Details
Table 126. Bayer Business Overview
Table 127. Bayer Product
Table 128. Bayer Revenue in Constipation Business (2015-2020) (Million US$)
Table 129. Bayer Recent Development
Table 130. Prestige Brands Holdings Company Details
Table 131. Prestige Brands Holdings Business Overview
Table 132. Prestige Brands Holdings Product
Table 133. Prestige Brands Holdings Revenue in Constipation Business (2015-2020) (Million US$)
Table 134. Prestige Brands Holdings Recent Development
Table 135. Janssen Pharmaceutical Company Details
Table 136. Janssen Pharmaceutical Business Overview
Table 137. Janssen Pharmaceutical Product
Table 138. Janssen Pharmaceutical Revenue in Constipation Business (2015-2020) (Million US$)
Table 139. Janssen Pharmaceutical Recent Development
Table 140. Shionogi Company Details
Table 141. Shionogi Business Overview
Table 142. Shionogi Product
Table 143. Shionogi Revenue in Constipation Business (2015-2020) (Million US$)
Table 144. Shionogi Recent Development
Table 145. Albireo Pharma Company Details
Table 146. Albireo Pharma Business Overview
Table 147. Albireo Pharma Product
Table 148. Albireo Pharma Revenue in Constipation Business (2015-2020) (Million US$)
Table 149. Albireo Pharma Recent Development
Table 150. Renexxion Company Details
Table 151. Renexxion Business Overview
Table 152. Renexxion Product
Table 153. Renexxion Revenue in Constipation Business (2015-2020) (Million US$)
Table 154. Renexxion Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Constipation Market Share by Type: 2020 VS 2026
Figure 2. Chronic Idiopathic Constipation (CIC) Features
Figure 3. Irritable Bowel Syndrome With Constipation (IBS-C) Features
Figure 4. Opioid-Induced Constipation (OIC) Features
Figure 5. Global Constipation Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Constipation Report Years Considered
Figure 10. Global Constipation Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Constipation Market Share by Regions: 2020 VS 2026
Figure 12. Global Constipation Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Constipation Market Share by Players in 2019
Figure 15. Global Top Constipation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Constipation as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Constipation Revenue in 2019
Figure 17. North America Constipation Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Constipation Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Constipation Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Constipation Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Constipation Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Constipation Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Constipation Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
オピオイド誘発性便秘治療の世界市場（～2026年） There are multiple drugs in the pipeline for opioid induced constipation treatment. Upon approval, these drugs will face little competition in this market which is largely untapped. There have not been many stable choices in the pharmaceutical industry for opioid induced constipation treatment over …- オピオイド誘発性便秘（OIC）治療の世界市場（～2026年） Market Analysis and Insights: Global Opioid-Induced Constipation (OIC) Treatment Market The global Opioid-Induced Constipation (OIC) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Opioid-Induced Constipation…
- 便秘治療の世界市場（～2026年） Constipation refers to bowel movements that are infrequent or hard to pass. The stool is often hard and dry. Other symptoms may include abdominal pain, bloating, and feeling as if one has not completely passed the bowel movement. Market Analysis and Insights: Global Constipation Treatment Market The…
- オピオイド誘発性便秘（OIC）治療薬の世界市場（～2026年） Opioid-induced constipation (OIC) is a common adverse effect experienced by many patients on opioid therapy for chronic pain. OTC medications include stimulant laxatives, stool softeners, and enemas. Market Analysis and Insights: Global Opioid Induced Constipation (OIC) Drug Market The global Opioid…
- 慢性特発性便秘（CIC）治療薬の世界市場（～2026年） Chronic idiopathic constipation (CIC) is a health condition in which a person experiences chronic symptoms of constipation, yet no visible cause can be identified through standard diagnostic testing. The term idiopathic is used because it means there is no known cause. CIC includes symptoms of diffi…